← All tickers

Is NVAX Worth Buying in 2026?

Novavax Inc

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-08-16

Here’s whether Novavax Inc (NVAX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-5.07% over 10 days); weak 1-year return of -14.6%; 3-month momentum negative (-11.2%). Currently 32.8% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

NVAX is trading below its 200-day MA ($8.43) — a key warning sign the longer-term trend is under pressure. An RSI of 70.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -14.6% compares to +20.4% for SPY (trailed the market by 35.0%). The current 32.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $8,537 today
vs. S&P 500 (SPY) — same period trailed market by 35.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($8.43)
✗Above 50-day MA ($8.53)
✓RSI(14) neutral zone (30–70) — currently 70.0
✗Positive return (-14.6%)
!Within 10% of period high (−32.8%)
Period Range $8.05
$6.20 $11.97
RSI (14) 70.0
0 · OversoldOverbought · 100

Key Metrics

Price$8.05
Period Return-14.6%
Period High$11.97
Period Low$6.20
Drawdown−32.8%
MA-50$8.53
MA-200$8.43
RSI (14)70.0
Avg Volume (30d)3.2M
vs. SPYtrailed by 35.0%
Return Rank#840 of 1252

Trade NVAX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers